论文部分内容阅读
目的提高子宫颈病变检出率。方法将1324例慢性宫颈炎患者随机分成两组,TCT组686例和巴氏组638例,TCT组采用膜式液基超薄细胞检测宫颈细胞,巴氏组采用宫颈涂片巴氏染色法检测宫颈细胞。比较TCT组与巴氏涂片满意率。结果TCT组CINⅠ检出59例,占8.60%,巴氏组CINⅠ检出18例,占2.82%,两组检出率有显著差异(P<0.05)。TCT组CINⅡ～Ⅲ检出40例,占5.83%,巴氏组CINⅡ～Ⅲ检出8例,占1.25%,两组检出率有显著差异(P<0.05)。TCT组标本满意率为92.42%,巴氏组标本满意率为72.41%,两组比较有极显著差异(P<0.0001)。结论TCT可替代宫颈涂片巴氏染色法,减少漏诊,提高细胞学检查质量,能及时发现宫颈早期病变,是防止宫颈癌发生的有效措施。
Objective To improve the detection rate of cervical lesions. Methods A total of 1324 patients with chronic cervicitis were randomly divided into two groups: 686 cases in TCT group and 638 cases in Pasteur group. The TCT group was used to detect cervical cells by membrane liquid-based ultrathin cells. Pap test was performed by Pap smear Cervical cells. The satisfaction rate between TCT group and Pap smear was compared. Results There were 59 cases (8.60%) of CINⅠ in TCT group and 18 cases (2.82%) in CisⅠ in Pap test group, with a significant difference (P <0.05). There were 40 cases (5.83%) in CINⅡ ~ Ⅲ in TCT group and 8 cases (1.25%) in CINⅡ ~ Ⅲ in pasteurian group, the detection rate was significantly different between the two groups (P <0.05). The satisfaction rate of TCT group was 92.42%, while that of Pasteur group was 72.41%. There was significant difference between the two groups (P <0.0001). Conclusion TCT can replace pap smear of cervical smears, reduce misdiagnosis, improve the quality of cytological examination, and detect early lesions of cervix. It is an effective measure to prevent the occurrence of cervical cancer.